Newsnation
@newsnation·2.7M subscribers·86.7K videos
Novo Nordisk CEO criticized by lawmakers over high Ozempic price | On Balance
Posted
September 24, 2024
Views
1,691
Likes
11
Comments
9
Engagement
1.18%
September 24, 2024
1,691
11
9
1.18%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
7:00Now PlayingThe diabetes drug Ozempic could achieve what no other drug has done — not just aid in weight loss or heart disease, but potentially disrupt Big Pharma's control over drug prices. The cost varies significantly: $140 a month in Germany, $92 in the U.K. and $1,000 in the U.S. Vermont independent Sen. Bernie Sanders has weighed in on the issue. Dr. Drew Pinsky, chief medical board member of The Wellness Company, joins NewsNation's "On Balance" to discuss.
"On Balance with Leland Vittert" takes a critical look at some of the day's hottest subjects. Weekdays at 7p/6C. #OnBalance
NewsNation is your source for fact-based, unbiased news for all America.
More from NewsNation
Get our app
Find us on cable
How to watch on TV or streaming
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
